TrialThe Journal of antimicrobial chemotherapy2020

Sofosbuvir and daclatasvir compared with standard of care in the treatment of patients admitted to hospital with moderate or severe coronavirus infection (COVID-19): a randomized controlled trial.

Anahita Sadeghi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.